✦ LIBER ✦

Predicting response to second-line treatment with TaxotereR (Tax) in patients with non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy

✍ Scribed by Shepherd, F.A; Hammershaimb, L; Kim, Y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized study of taxotere (TAX) versu

✍ F. Shepherd; R. Gralla; R. Ramlau; K. Mattson; B. Bergman; P. Kraszko; R. Rudd; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Second-line docetaxel and gemcitabine co

✍ Faruk Tas; Cumhur Demir; Hakan Camlica; Zeki Ustuner; Erkan Topuz 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 95 KB

A prospective randomized trial of Taxote

✍ Shepherd, F; Dancey, J; Ramlau, R; Mattson, K; Gralla, R; Kim, Y; Berille, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB

P-37 Activity of carboplatin in patients

✍ Fernández, Yolanda; Esteban, Emilio; Fra, Joaquin; Mun˜iz, Isabel; Palacio, Isab 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Phase II Study of Docetaxel/Vinorelbine

✍ Alberto Muñoz; Itziar Rubio; Juan Manuel Mañé; Josefa Ferreiro; Ricardo Fernánde 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 140 KB

Phase I trial of bi-weekly paclitaxel an

✍ Tomonobu Koizumi; Fumiaki Yoshiike; Hitoshi Inou; Orie Hatayama; Mari Sasabayash 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 95 KB